ArticlePathology oncology research : POR2021

EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.

Györgyi A Nelhűbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.